3D printed composite scaffolds with dual small molecule delivery for mandibular bone regeneration
- 12 June 2020
- journal article
- research article
- Published by IOP Publishing in Biofabrication
- Vol. 12 (3), 035020
- https://doi.org/10.1088/1758-5090/ab906e
Abstract
Functional reconstruction of craniomaxillofacial defects is challenging, especially for the patients who suffer from traumatic injury, cranioplasty, and oncologic surgery. Three-dimensional (3D) printing/bioprinting technologies provide a promising tool to fabricate bone tissue engineering constructs with complex architectures and bioactive components. In this study, we implemented multi-material 3D printing to fabricate 3D printed PCL/hydrogel composite scaffolds loaded with dual bioactive small molecules (i.e. resveratrol and strontium ranelate). The incorporated small molecules are expected to target several types of bone cells. We systematically studied the scaffold morphologies and small molecule release profiles. We then investigated the effects of the released small molecules from the drug loaded scaffolds on the behavior and differentiation of mesenchymal stem cells (MSCs), monocyte-derived osteoclasts, and endothelial cells. The 3D printed scaffolds, with and without small molecules, were further implanted into a rat model with a critical-sized mandibular bone defect. We found that the bone scaffolds containing the dual small molecules had combinational advantages in enhancing angiogenesis and inhibiting osteoclast activities, and they synergistically promoted MSC osteogenic differentiation. The dual drug loaded scaffolds also significantly promoted in vivo mandibular bone formation after 8-week implantation. This work presents a 3D printing strategy to fabricate engineered bone constructs, which can likely be used as off-the-shelf products to promote craniomaxillofacial regeneration.Keywords
Funding Information
- NIH (R01 AR073225, R21AI140026, P30GM106397)
- China Scholarship Council
This publication has 85 references indexed in Scilit:
- Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in FibroblastsPLOS ONE, 2011
- Strontium Enhances Osteogenic Differentiation of Mesenchymal Stem Cells and In Vivo Bone Formation by Activating Wnt/Catenin SignalingThe International Journal of Cell Cloning, 2011
- The 3′ UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular CarcinomaPLOS ONE, 2011
- Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructureActa Biomaterialia, 2010
- Cellular and Molecular Mechanisms of Bone RemodelingJournal of Biological Chemistry, 2010
- Endothelial cells influence the osteogenic potential of bone marrow stromal cellsBioMedical Engineering OnLine, 2009
- Engineering Craniofacial Structures: Facing the ChallengeJournal of Dental Research, 2009
- Dose Effect of Dual Delivery of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-2 on Bone Regeneration in a Rat Critical-Size Defect ModelTissue Engineering, Part A, 2009
- NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiationGene, 2006
- Strontium ranelate: A physiological approach for optimizing bone formation and resorptionBone, 2006